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Aims: Obesity and obesity-associated phenotypes are linked to the chromosome12q24 locus, the non-insulin-
dependent-diabetes 2 (NIDDM2) locus. The gene of proteasome modulator 9 (PSMD9) lies in the NIDDM2 region
and is linked to type 2 diabetes (T2D), microvascular and macrovascular complications of T2D.
We aimed at studying whether the PSMD9 T2D risk single nucleotide polymorphisms (SNPs) IVS3+nt460, IVS3+nt437,
and 197G are linked to obesity, overweight status and waist circumference in Italian T2D families.
Methods and results: We screened 200 Italians T2D siblings/families for PSMD9 variants. Using Merlin software, we
performed non-parametric linkage analysis to test for linkage with obesity and overweight condition and variance
component analysis to test for linkage with waist circumference in our T2D siblings/families dataset.
Our study shows that the PSMD9 SNPs IVS3+nt460, IVS3+nt437, and 197G are in linkage with overweight condition
and waist circumference in Italians. The statistical power tests performed via simulations on real data confirm that
the results are not due to random chance.
Conclusions: In summary, the linkage strategy using a homogeneous family/subject dataset can identify a gene
contributing to a complex trait. PMSD9 may be at least one of the genes responsible for the linkage to obesity and
obesity-associated phenotypes at the locus 12q24 in other populations.
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Several groups reported linkage within the NIDDM2 (non-
insulin-dependent diabetes mellitus) locus at chromosome
12q24 to T2D, obesity, central fat mass and waist circum-
ference [1-8]. Within the 12q24 locus lies the gene of
proteasome modulator 9 (PSMD9), a transcriptional regu-
lator of the insulin gene, highly expressed in pancreatic is-
lets [9]. PSMD9 is a ubiquitous protein of eukaryotic cells
and part of the 26S proteasome complex, contributing to
intracellular proteins degradation into antigenic peptides in
the immune response to antigen presentation by MHC class
I cells (www.genecards.org/cgi-bin/carddisp.pl?gene=PSMD9).
PSMD9 may play a role in inflammation as part of the
autoimmune process [10]. Further, PSMD9 regulates theCorrespondence: claudia.gragnoli@gmail.com
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Since PSMD9 is a coactivator of insulin gene transcription
[9], and in pancreatic overexpression of transgenic mice cause
diabetes [11], PSMD9 variants may contribute to T2D as well
as to obesity, overweight status and visceral obesity.
We reported that PSMD9 may rarely cause T2D by
unique mutations [12] and that is linked to T2D [13],
maturity-onset diabetes of the young 3 (MODY3) [14],
T2D-microvascular [15-18] and T2D-macrovascular com-
plications [19], hypercholesterolemia [20], hypertension
[21], carpal tunnel syndrome [22], and depression [23]. Of
note, the 12q24 locus is not only linked to T2D [24],
macrovascular [25,26] and microvascular disease [27], but
also to dyslipidemia [28], hypertension, obesity, [2], body
mass index and C-reactive protein jointly [29], cat-specific
IgE and total IgE in asthma [30], and most interestingly to
bipolar disorder [31] and depression [32]. Also a recent
study has reported that a deletion at the locus 12q24.33 is
significantly correlated with height, suggesting that thisThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ute to height variation in human populations [33].
The aim of the present study is to identify whether
PSMD9 IVS3+nt460, IVS3+nt437, and 197G single nu-
cleotide polymorphisms (SNPs) may be linked to max-
imum lifetime obesity, maximum lifetime overweight
status and visceral obesity measured by waist circumfer-
ence in an Italian family dataset.
Methods
Ethics statement
The subjects were all recruited from center Italy follow-
ing the Helsinki declaration guidelines. Subjects gave
written informed consent and the Penn State College of
Medicine Ethical Committee approved the study.
Families
We recruited 200 Italian T2D affected siblings and fam-
ilies. We excluded all families with identical twins and
confirmed that at least three generations were Italian.
Italians are a homogeneous population living in a penin-
sula and they are suitable for genetic studies due to lack
of genetic admixture. This family dataset has helped
studying and identifying T2D and MODY genes contrib-
uting to disease [34-48].
Clinical phenotyping
We characterized the Italian families for maximum life-
time body mass index [BMI=weight in Kg/(height in m)2],
indicating as overweight those with maximum lifetime
BMI ≥25 and as obese those with maximum lifetime
BMI ≥30. We measured also the waist circumference in
cm. BMI and waist circumference during pregnancy in
females were not considered. Phenotypes are described
as unknown if diagnosis is unclear because data are
lacking. In our 200 Italian families, data are less than
100% for each phenotype.
Sequencing
Via PCR, we amplified with specific primers in the af-
fected and unaffected family members the IVS3 PSMD9
region containing the +nt460 A/G and +nt437 C/T SNPs
and the exon 5 coding region containing the E197G A/G
SNP. We directly sequenced the PCR products, status
post-purification via EXOSAP-IT on an automated ABI




Prevalence = phenotype prevalence among the family subjects studied; Families =
linkage analysis by Merlin; Empirical P-value = derived from 1000 replicates by usin
Obesity = presence of BMI ≥30.Linkage analysis
We tested in the 200 Italians families for linkage of the
PSMD9 SNPs with maximum lifetime obesity, maximum
lifetime overweight condition and waist circumference.
The non-parametric linkage analysis for the qualitative
phenotypes and the variance component analysis for the
quantitative trait were performed by using Merlin software
[49], calculating the allelic frequency from the total 200
genotyped families. Merlin analyzed all the informative
families within this dataset. All results are reported as
LOD scores calculated by Merlin.
Simulations
For each test performed, to exclude the presence of any
results due to random chance, we calculated how many
times similar P-values were expected by chance in 1,000
replicates of simulations by using the gene dropping
method: this analysis replaces real data with simulated
data, while maintaining the pedigree structure, allele fre-
quencies and recombination fraction. These datasets are
generated under the null hypothesis of no linkage.
Results
The results (LOD score, P-value and empirical P-value)
of the non-parametric linkage analysis performed for the
qualitative phenotypes overweight status and obesity are
shown in Table 1.
The results of the variance component analysis per-
formed for the quantitative trait waist circumference in
cm with the LOD score, P-value, empirical P-value, trait
heritability and trait heritability attributable to the SNPs
under study are reported in Table 2.
Discussion
Our analyses show that the PSMD9 IVS3+nt460, IVS3
+nt437, and 197G SNPs are in linkage with maximum
lifetime overweight and with waist circumference, repre-
senting visceral obesity. Further, there is a trend towards
linkage with obesity. The reduced number of families
meeting the criteria for obesity may have reduced the
power to detect linkage.
The 12q24.2 chromosome bears the NIDDM2 locus,
the MODY3 gene HNF-1α, cause of T2D and MODY3,
respectively. We previously reported that unique rare
PSMD9 mutations contribute to T2D and that the IVS3
+nt460, IVS3+nt437, and 197G SNPs are linked to T2D200 Italian families by Merlin software
Lod score P-value Empirical P-value
1.22 0.009 0.004
0.62 0.050 0.053
families number analyzed; Lod score = derived from the non-parametric
g the gene dropping method; Overweight = presence of BMI ≥25;
Table 2 Variance component linkage analysis of the waist circumference in cm of the 200 Italian families by Merlin
software
Quantitative trait Families Trait heritability Gene trait heritability Lod score P-value Empirical P-value
Waist in cm 108 50.66% 49.17% 0.93 0.020 0.023
Families = families number analyzed; Lod score = derived from the quantitative trait analysis by Merlin; Empirical P-value = derived from 1000 replicates by using
the gene dropping method; Trait Heritability = Heritability of the quantitative trait calculated by Merlin; Trait Heritability attributable to the PSMD9 SNPs.
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PSMD9 linkage to micro- and macro-vascular disease of
T2D [15-19], hypercolesterolemia [20], hypertension [21]
and depression [23] suggest a potential role in mediating
an inflammatory response, which could explain the pres-
ence of linkage to the obesity-associated phenotypes.
Our results demonstrating the presence of linkage to
overweight condition as well as to waist circumference
are encouraging as the same locus is in linkage in other
populations with obesity, central fat mass and waist
circumference [1,2,8]. The data should be replicable in
other ethnic groups and are of high interest to the
groups who revealed linkage in the same locus, which
may be explained by the PSMD9 variants.
In addition, we again prove the strength and validity of
the linkage approach in identifying genes in complex
disorders. In fact, family-based linkage studies are safer
in their statistical nature compared to association stud-
ies. Also, we consider that the use of microsatellites as
markers in the past may have negatively affected the re-
sults of the linkage, especially in polygenic diseases and
with the use of affected siblings, as these markers may
undergo duplications and mutations in vivo. In fact, pre-
viously we could not identify linkage with T2D at 12q24
using multiple highly informative and polymorphic
microsatellites within the same family dataset (data not
shown) in which the linkage was identified using SNPs
[13]. Hence, SNP-based linkage studies are more reliable.
Also, the family dataset should be ethnically
homogenous to allow results to be revealed.
PSMD9 should be screened in other populations for
mutations and common variants in families with obesity,
overweight condition and visceral obesity.
Interestingly, the reported 12q24 locus linkage to cat-
specific IgE and total IgE in asthma [30] could offer a
possible explanation of the pleiotropic effects of such
locus. In fact, the identified 12q24 linkage to multiple
disorders including T2D [24], micro- and macrovascular
disease [25-27], hypertension [2], body mass index and
C-reactive protein [29], dyslipidemia [28], depression [32]
and bipolar disorder [31] supports the idea that there
could be a common underlying pathogenetic factor trig-
gering the above-mentioned multiple disorders, such as
an exaggerated inflammatory response or a deregulated
autoimmune response leading to disease status. And this
hypothesis fits well with the role of PSMD9 in the prote-
asome complex 26S processing the antigens for theimmune response (www.genecards.org/cgi-bin/carddisp.
pl?gene=PSMD9). PSMD9 may play an inflammatory role
in autoimmunity [10] with pleiotropic effects. Of note, the
finding that 12q24.33 deletion affects height [33] could
represent an outcome of the inheritance of factors predis-
posing to pre-disease states and thus affecting adult final
growth. In fact, height is inversely associated with cardio-
vascular disease [50] and cardiovascular risk factors, such
as insulin resistance [51]. Thus, the 12q24 locus could
bear the gene or genes contributing to waist circumfer-
ence, insulin resistance, cardiovascular disease, depression
and height determination. It would be of interest to study
the role of PSMD9 in asthma and IgE-mediated disorders
as well as in final adult height.
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